Skip to main content
. 2017 Nov 24;20(8):1122–1132. doi: 10.1093/neuonc/nox228

Fig. 1.

Fig. 1

Overall survival, disease-free survival, and progression-free survival of children with medulloblastoma and germline SUFU mutation (n = 22).